Fever News and Research

RSS
Lab results change in consistent ways during the course of Kawasaki disease

Lab results change in consistent ways during the course of Kawasaki disease

Celgene reports final results from REVLIMID-rituximab combination phase II study for relapsed/refractory CLL

Celgene reports final results from REVLIMID-rituximab combination phase II study for relapsed/refractory CLL

Celgene announces data from REVLIMID Phase III study on high-risk asymptomatic smoldering MM

Celgene announces data from REVLIMID Phase III study on high-risk asymptomatic smoldering MM

Researchers discover how bloodstream malaria infection manipulates immune system

Researchers discover how bloodstream malaria infection manipulates immune system

Ruxolinitib reduces spleen size by 35% in patients with myelofibrosis

Ruxolinitib reduces spleen size by 35% in patients with myelofibrosis

Celgene reports final results from REVLIMID plus VIDAZA phase II study on higher-risk MDS

Celgene reports final results from REVLIMID plus VIDAZA phase II study on higher-risk MDS

Celgene announces interim results of REVLIMID study on CLL

Celgene announces interim results of REVLIMID study on CLL

Breakthroughs in hematopoietic cell transplantation to be presented at 53rd ASH meeting

Breakthroughs in hematopoietic cell transplantation to be presented at 53rd ASH meeting

Alios BioPharma, Vertex initiate ALS-2200 and ALS-2158 clinical study in HCV

Alios BioPharma, Vertex initiate ALS-2200 and ALS-2158 clinical study in HCV

Experimental sublingual vaccine shows promise against influenza infection

Experimental sublingual vaccine shows promise against influenza infection

Inviragen presents DENVax Phase 1 trial results on dengue at ASTMH annual meeting

Inviragen presents DENVax Phase 1 trial results on dengue at ASTMH annual meeting

Fatal snakebites 'vastly underreported,' researchers report at annual ASTMH meeting

Fatal snakebites 'vastly underreported,' researchers report at annual ASTMH meeting

Positive results from Genentech's pertuzumab plus Herceptin Phase III study on HER2-positive mBC

Positive results from Genentech's pertuzumab plus Herceptin Phase III study on HER2-positive mBC

Updated data from Novartis Afinitor plus everolimus Phase III study on advanced breast cancer

Updated data from Novartis Afinitor plus everolimus Phase III study on advanced breast cancer

Vaccine against Ebola developed

Vaccine against Ebola developed

Health Alliance, Bayer sign outcomes-based contract to support MS patients

Health Alliance, Bayer sign outcomes-based contract to support MS patients

Researchers discover new tick-borne infection

Researchers discover new tick-borne infection

Measles raises its head again in Europe after years of suppression: Report

Measles raises its head again in Europe after years of suppression: Report

NanoViricides submits pre-IND Meeting Request for FluCide to FDA

NanoViricides submits pre-IND Meeting Request for FluCide to FDA

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.